Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

AVNS stock hub

Avanos Medical, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AVNSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.2B

NYSE

Market data

Live price

Current market quote for this ticker.

Current price

AVNS

In the news

Latest news · AVNS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E21.6

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-9.2

P25 -105.6P50 -46.5P75 -3.1

ROIC2

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AVNS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

226

Groups with data

Currency

USD

Showing 226 of 226 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001606498
Company name	Avanos Medical, Inc.
Country	United States
Country code	US
Cusip	05350V106
Employees	2,287
Employees Change	60%
Employees Change Percent	2.69
Enterprise value	$1.2B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Isin	US05350V1061
Last refreshed	2026-05-10
Market cap	$1.2B
Market cap category	Small-Cap
Price	$24.8
Price currency	USD
Rev Per Employee	313,030.17x
Sector	Healthcare
Sic	3842
Symbol	AVNS
Website	https://avanos.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.41%
EV Sales Forward	1.69x
EV/EBIT	75.25x
EV/EBITDA	22.08x
EV/FCF	164.54x
EV/Sales	1.72x
FCF yield	0.65%
Forward P/E	21.57x
P/B ratio	1.48x
P/S ratio	1.62x
PS Forward	1.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.29%
EBITDA Margin	7.81%
FCF margin	1.05%
Gross margin	50.05%
Gross Profit	$358.3M
Gross Profit Growth	-4.78%
Gross Profit Growth Q	4.9%
Gross Profit Growth3 Y	-3.29%
Gross Profit Growth5 Y	-0.4%
Net Income	$-74.4M
Net Income Growth Q	-22.73%
Net Income Growth Years	1%
Pretax Margin	-9.54%
Profit Margin	-10.39%
Profit Per Employee	$-32,532
ROA	0.95
Roa5y	0.86
ROCE	1.78
ROE	-9.18
Roe5y	-9.61
ROIC	1.96
Roic5y	1.62

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-1.66%
Cagr1y	97.23%
Cagr3y	1.14%
Cagr5y	-9.63%
EPS Growth Q	-21.66
EPS Growth Years	1
FCF Growth	-93.42%
FCF Growth3 Y	-51.06%
OCF Growth	-72.69%
OCF Growth10 Y	-9.57%
OCF Growth3 Y	-23.6%
Revenue Growth	3.87x
Revenue Growth Q	8.78x
Revenue Growth Quarters	6x
Revenue Growth Years	2x
Revenue Growth3 Y	1.53x
Revenue Growth5 Y	0.02x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.66
Assets	$1.1B
Cash	$65.6M
Current Assets	$325M
Current Liabilities	$131.2M
Debt	$138.4M
Debt EBITDA	$2.06
Debt Equity	$0.18
Debt FCF	$18.45
Equity	$782.1M
Interest Coverage	2.28
Liabilities	$268M
Long Term Assets	$725.1M
Long Term Liabilities	$136.8M
Net Cash	$-72.8M
Net Cash By Market Cap	$-6.27
Net Debt EBITDA	$1.3
Net Debt Equity	$0.09
Net Debt FCF	$9.71
Tangible Book Value	$273.4M
Tangible Book Value Per Share	$5.86
WACC	12.03

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.48
Inventory Turnover	2.56
Net Working Capital	$149.5M
Quick ratio	1.29
Working Capital	$193.8M
Working Capital Turnover	$3.5

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.92%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-15.39%
1Y total return	97.14%
200-day SMA	13.47
3Y total return	3.46%
50-day SMA	17.88
50-day SMA vs 200-day SMA	50over200
5Y total return	-39.72%
All Time High	72.96
All Time High Change	-66.01%
All Time High Date	2018-09-05
All Time Low	9.3
All Time Low Change	166.58%
All Time Low Date	2025-08-05
ATR	0.35
Beta	1.59
Beta1y	2.61
Beta2y	1.3
Ch YTD	120.8
High	24.81
High52	24.81
High52 Date	2026-05-08
High52ch	-0.04%
Low	24.76
Low52	9.3
Low52 Date	2025-08-05
Low52ch	166.58%
Ma50ch	38.67%
Price vs 200-day SMA	84.13%
RSI	90.3
RSI Monthly	66.25
RSI Weekly	83.04
Sharpe ratio	1.11x
Sortino ratio	3.4
Total Return	-0.92%
Tr YTD	120.8
Tr1m	81.15%
Tr1w	0.57%
Tr3m	69.98%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$0.16
Earnings EPS Estimate Growth	-38.46
Earnings Revenue Estimate	169,862,000x
Earnings Revenue Estimate Growth	1.41x
Operating Income	$16.4M
Operating Income Growth	-55.31
Operating Income Growth Q	10.11
Operating Income Growth3 Y	-24.95
Operating Income Growth5 Y	-0.95
Operating margin	2.29

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	42,387,026%
Float Percent	90.52%
Net Borrowing	-9,400,000
Shares Insiders	2.5%
Shares Institutions	86.53%
Shares Out	46,824,793
Shares Qo Q	2.37%
Shares Yo Y	0.92%
Short Float	4.73%
Short Ratio	1.17
Short Shares	4.28

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-5M
Average Volume	2,700,691.35x
Bv Per Share	16.76
CAPEX	$-29.2M
Ch10y	-15.39
Ch1m	81.15
Ch1w	0.57
Ch1y	97.14
Ch3m	69.98
Ch3y	3.46
Ch5y	-39.72
Ch6m	120.8
Change	0.12%
Change From Open	0
Close	24.77
Days Gap	0.12
Depreciation Amortization	39,500,000
Dollar Volume	23,954,072
Earnings Date	2026-05-05
Earnings Time	bmo
EBIT	$16.4M
EBITDA	$55.9M
EPS	$-1.6
F Score	5
FCF	$7.5M
FCF EV Yield	0.61x
FCF Per Share	$0.16
Financing CF	-11,100,000
Fiscal Year End	December
Founded	2,014
Goodwill	394,000,000
Income Tax	$6.1M
Investing CF	-59,200,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-24
Ma150	14.08
Ma150ch	76.1%
Ma20	24.16
Ma20ch	2.63%
Net CF	-31,400,000
Next Earnings Date	2026-08-04
Open	24.8
Optionable	Yes
P FCF Ratio	154.8
P OCF Ratio	31.64
Position In Range	80
Ppne	150,500,000
Price Date	2026-05-08
Price EBITDA	$20.77
Ptbv Ratio	4.25
Relative Volume	0.36x
Revenue	715,900,000x
SBC By Revenue	1.75x
Share Based Comp	12,500,000
Tax By Revenue	0.85x
Tr6m	120.84%
Us State	Georgia
Volume	965,890
Z Score	1.2

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AVNS pay a dividend?

Capital-return profile for this ticker.

Performance

AVNS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AVNS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+86.5%

Float: +90.5% of shares outstanding

Insider ownership

+2.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

AVNS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

90.3

Above 70: short-term overbought

Price vs 200-day MA

+84.1%

50/200-day relationship not available

Beta (5Y)

1.59

More volatile than the market

Sharpe ratio

1.11

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AVNS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current AVNS stock rating?

Avanos Medical, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full AVNS analysis?

The full report lives at /stocks/AVNS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for AVNS?

The latest report frames AVNS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the AVNS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.